Temporary anti-CD-25 treatment results in tolerance development in syngeneically grafted autoimmune diabetic recipients

Transplant Proc. 1991 Feb;23(1 Pt 1):741-2.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • Cyclosporins / therapeutic use
  • Diabetes Mellitus, Experimental / immunology
  • Diabetes Mellitus, Experimental / surgery*
  • Immune Tolerance
  • Immunosuppression Therapy*
  • Islets of Langerhans Transplantation / immunology*
  • Lymphocyte Transfusion
  • Rats
  • Rats, Inbred BB
  • Receptors, Interleukin-2 / immunology*
  • Transplantation, Isogeneic

Substances

  • Antibodies, Monoclonal
  • Cyclosporins
  • Receptors, Interleukin-2